Experimental Ebola trial begins in Congo as death toll tops 500
The WHO-sponsored trial will test Mapp Biopharmaceutical Inc.’s monoclonal antibody cocktail MBP134 and Gilead Sciences Inc.’s antiviral remdesivir
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)